Pfizer’s Pol Vandenbroucke on the changing industryAhead of the 2019 eyeforpharma Barcelona conference, we asked speaker Pol Vandenbroucke – chief medical officer of the Share XPfizer’s Pol Vandenbroucke on the changing industryhttps://pharmaphorum.com/views-analysis-sales-marketing/pfizers-pol-vandenbroucke-on-the-changing-industry/
JP Morgan Healthcare: where science, tech and finance collideWelcome to 2019! Hopefully by now you’re managing to ease yourself back into things, no doubt with good Share XJP Morgan Healthcare: where science, tech and finance collidehttps://pharmaphorum.com/views-analysis-sales-marketing/jp-morgan-healthcare-science-tech-finance-collide/
Brexit and beyond: the challenges ahead for pharmaBrexit, and the political fallout from approving any deal, will continue to dominate British politics in 2019. It Share XBrexit and beyond: the challenges ahead for pharmahttps://pharmaphorum.com/views-analysis-sales-marketing/brexit-challenges-ahead-pharma/
The constants of pharma marketingVeteran marketer Neal Wolff’s career has taken him from big pharma to US-based biotech Nevakar. We spoke to Share XThe constants of pharma marketinghttps://pharmaphorum.com/views-analysis-sales-marketing/the-constants-of-pharma-marketing/
The end of siloed healthcareFor the past eight years Syneos Health has been issuing annual healthcare trends forecasts, usually separated into Communications Share XThe end of siloed healthcarehttps://pharmaphorum.com/views-analysis-sales-marketing/the-end-of-siloed-healthcare/
2018 in review: Humira biosimilars arrive in EuropeThe emergence this year of Humira biosimilars in Europe followed a period of sustained momentum around the cheaper Share X2018 in review: Humira biosimilars arrive in Europehttps://pharmaphorum.com/views-analysis-sales-marketing/2018-review-humira-biosimilars-europe/
Disrupt or be disrupted, experts warn pharmaPharma is playing catch-up with digital technology – but in this age of big data and AI, there Share XDisrupt or be disrupted, experts warn pharmahttps://pharmaphorum.com/views-analysis-sales-marketing/disrupt-disrupted-experts-warn-pharma/
How to make pharma marketing content unskippableAs long as pharma companies could afford an army of reps to get their advertising messaging directly to Share XHow to make pharma marketing content unskippablehttps://pharmaphorum.com/views-analysis-sales-marketing/how-to-make-pharma-marketing-content-unskippable/
Insight, market monitoring and assessing whether a brand plan is fit for purposeThis article is the last in a series of three from Osprey Health Consulting. In this third article Share XInsight, market monitoring and assessing whether a brand plan is fit for purposehttps://pharmaphorum.com/views-analysis-sales-marketing/insight-market-monitoring-and-assessing-whether-a-brand-plan-is-fit-for-purpose/
